Enzo Biochem Inc
NYSE:ENZ
Enzo Biochem Inc
NYSE:ENZ
Price:
1.04 USD
Market Closed
Updated:
May 4, 2024
Enzo Biochem Inc
Revenue
|
Enzo Biochem Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Enzo Biochem Inc
NYSE:ENZ
|
Revenue
$63.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Enzo Biochem Inc
Revenue Breakdown
Breakdown by Geography
Enzo Biochem Inc
Enzo Biochem Inc
|
Total Revenue:
31.1m
USD
|
|
United States:
18.6m
USD
|
|
Europe:
8.4m
USD
|
|
Asia Pacific:
4.1m
USD
|
Breakdown by Segments
Enzo Biochem Inc
Enzo Biochem Inc
|
Total Revenue:
31.1m
USD
|
|
Product Revenue:
31.1m
USD
|
See Also
What is Enzo Biochem Inc's Revenue?
Revenue
63.5m
USD
63.5m
USD
Based on the financial report for Jan 31, 2024, Enzo Biochem Inc's Revenue amounts to 63.5m USD.
What is Enzo Biochem Inc's Revenue growth rate?
Revenue CAGR 10Y
-4%
-4%
Over the last year, the Revenue growth was -22%. The average annual Revenue growth rates for Enzo Biochem Inc have been -13% over the past three years , -6% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
